Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.71 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.54 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.54 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | GGT1 | P19440 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27528077 | 0.95 | TSHR (0.71) | TSHRTDP1L3MBTL1PTGS2MAPK1 | |
| SCHEMBL4730460 | 0.94 | ALDH1A1 (0.72) | TSHRTDP1L3MBTL1PTGS2MAPK1 | |
| SCHEMBL11314352 | 0.94 | ALDH1A1 (0.72) | TSHRTDP1L3MBTL1PTGS2MAPK1 | |
| SCHEMBL4732320 | 0.94 | ALDH1A1 (0.72) | TSHRTDP1L3MBTL1PTGS2MAPK1 | |
| SCHEMBL4728775 | 0.94 | ALDH1A1 (0.72) | TSHRTDP1L3MBTL1PTGS2MAPK1 | |
| SCHEMBL4728781 | 0.94 | ALDH1A1 (0.72) | TSHRTDP1L3MBTL1PTGS2MAPK1 | |
| SCHEMBL11985699 | 0.92 | PTGS2 (0.72) | TSHRTDP1L3MBTL1PTGS2MAPK1 | |
| SCHEMBL12715080 | 0.91 | PTGS2 (0.75) | TSHRTDP1L3MBTL1PTGS2MAPK1 | |
| SCHEMBL9446603 | 0.91 | PTGS2 (0.75) | TSHRTDP1L3MBTL1PTGS2MAPK1 | |
| SCHEMBL4782034 | 0.91 | ALDH1A1 (0.69) | TSHRTDP1L3MBTL1PTGS2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2994505-B1 | A PROCESS FOR DEPOLYMERIZATION OF LIGNIN | COUNCIL SCIENT IND RES (IN) | 2017-04-05 | — | — | EP | claimed |
| US-9550710-B2 | Process for depolymerization of lignin | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2017-01-24 | — | — | US | claimed |
| US-20160168062-A1 | PROCESS FOR DEPOLYMERIZATION OF LIGNIN | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-06-16 | — | — | US | claimed |
| EP-2994505-A1 | A PROCESS FOR DEPOLYMERIZATION OF LIGNIN | Council of Scientific & Industrial Research (IN) | 2016-03-16 | — | — | EP | claimed |
| WO-2014181360-A1 | A PROCESS FOR DEPOLYMERIZATION OF LIGNIN | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-11-13 | — | — | WO | claimed |
| CN-104829757-B | A kind of ingredient of solid catalyst of olefin polymerization acid esters compound containing bigcatkin willow and its preparation method and application | 中国科学院化学研究所 | 2018-04-27 | — | — | CN | disclosed |
| EP-3173072-A1 | CONVENIENTLY IMPLANTABLE SUSTAINED RELEASE DRUG COMPOSITIONS | Ramscor, Inc. (US) | 2017-05-31 | — | — | EP | disclosed |
| EP-2994505-B1 | A PROCESS FOR DEPOLYMERIZATION OF LIGNIN | COUNCIL SCIENT IND RES (IN) | 2017-04-05 | — | — | EP | disclosed |
| US-9550710-B2 | Process for depolymerization of lignin | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2017-01-24 | — | — | US | disclosed |
| US-20160168062-A1 | PROCESS FOR DEPOLYMERIZATION OF LIGNIN | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-06-16 | — | — | US | disclosed |
| EP-2994505-A1 | A PROCESS FOR DEPOLYMERIZATION OF LIGNIN | Council of Scientific & Industrial Research (IN) | 2016-03-16 | — | — | EP | disclosed |
| US-20150273066-A1 | CONVENIENTLY IMPLANTABLE SUSTAINED RELEASE DRUG COMPOSITIONS | RAMSCOR INC (US) | 2015-10-01 | — | — | US | disclosed |
| US-20080038316-A1 | Conveniently implantable sustained release drug compositions | RAMSCOR, INC. | 2008-02-14 | — | — | US | disclosed |
| EP-1793803-A2 | CONVENIENTLY IMPLANTABLE SUSTAINED RELEASE DRUG COMPOSITIONS | Ramscor, Inc. (US) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006039336-A2 | CONVENIENTLY IMPLANTABLE SUSTAINED RELEASE DRUG COMPOSITIONS | RAMSCOR, INC. (US) | 2006-04-13 | — | — | WO | disclosed |
| US-20060073182-A1 | Conveniently implantable sustained release drug compositions | RAMSCOR, INC. | 2006-04-06 | — | — | US | disclosed |
| US-4287174-A | CONTAINING A QUATERNARY AMMONIUM CARBOXY ZWITTERIONIC COMPOUND AND AN ANTACID | THE PROCTOR & GAMBLE COMPANY (US) | 1981-09-01 | — | — | US | disclosed |
| US-4275059-A | IN COMBINATION WITH A DIPHOSPHONATE COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 1981-06-23 | — | — | US | disclosed |
| US-4199576-A | DERIVATIVES OF SALICYCLIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 1980-04-22 | — | — | US | disclosed |
| EP-0004686-A2 | Anti-ulcer composition | THE PROCTER & GAMBLE COMPANY (US) | 1979-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168062-A1 | PROCESS FOR DEPOLYMERIZATION OF LIGNIN | DCXR, BROX, LCT | TSHR 4864/4885TDP1 2699/4885L3MBTL1 923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.